SHAREHOLDER UPDATE: Glancy Prongay & Murray LLP Appointed Lead Counsel in Securities Class Action Against Acutus Medical, Inc.
Glancy Prongay & Murray LLP (“GPM”) announces that it has been appointed Lead Counsel in the securities class action against Acutus Medical, Inc. (“Acutus” or the “Company”) (NASDAQ: AFIB...
Acutus Medical, Inc. (AFIB) Q2 2022 Earnings Call Transcript
AFIB earnings call for the period ending June 30, 2022.
Acutus Medical Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CARLSBAD, Calif., Aug. 02, 2022 (GLOBE NEWSWIRE) -- Acutus Medical, Inc. (“Acutus” or the “Company”) (Nasdaq: AFIB), an arrhythmia management company...